Randomized controlled trial to evaluate the prediction of the effectiveness for HLA-oriented therapy in gastric and colorectal cancer.
Not Applicable
- Conditions
- Gastric cancer Colorectal cancer
- Registration Number
- JPRN-UMIN000037475
- Lead Sponsor
- Japan cancer treatment and behavior study group(JCTB)
- Brief Summary
We failed to confirm that HLA B40 and B51 antigens significantly associated with response to PSK therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 432
Inclusion Criteria
Not provided
Exclusion Criteria
1. Double cancer. 2. Prior cytotoxic or radiation therapy. 3. Abnormal bone marrow, hepatic and renal function 4. Severe cardiac, hepatic and lung failure, and an attending doctor was considered unsuitable.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method